Status:
RECRUITING
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Acute Kidney Injury
Chronic Kidney Diseases
Eligibility:
All Genders
18-99 years
Brief Summary
Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its persistence (i.e. downstrea...
Detailed Description
Acute renal failure (ARF) and chronic kidney disease (CKD) are frequent pathologies (850 million people are affected worldwide). Renal failure is associated with an increased morbidity and mortality, ...
Eligibility Criteria
Inclusion
- Patients (\> 18 year of age) with kidney disease or at risk to develop a kidney disease,
- Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France)
Exclusion
- consent deny
- inability of the patient or its family to give consent.
Key Trial Info
Start Date :
September 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2032
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05318196
Start Date
September 5 2022
End Date
September 1 2032
Last Update
March 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rangueil University Hospital
Toulouse, France, 31059